Twist Bioscience (TWST)

• Market cap: $3.01B
• 1 day: 3.35%
• 5 days: 4.63%
• 1 month: 28.97%
• 3 months: 58.46%
• 6 months: 77.56%
• Year to date: 51.47%
• 1 year: 0.88%
• 5 years: -70.59%
• 10 years: 250.43%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Employees: 979